OMKARPH

Omkar Pharmachem Share Price

₹28.99 +0.71 (2.51%)

04 Dec, 2024 00:16

SIP TrendupStart SIP in OMKARPH

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume0

Investment Returns

  • Over 1 Month + 7.61%
  • Over 3 Month + 4.36%
  • Over 6 Month + 32.07%
  • Over 1 Year + 33.1%
SIP Lightning

Smart Investing Starts Here Start SIP with Omkar Pharmachem for Steady Growth!

Invest Now

Omkar Pharmachem Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Omkar Pharmachem Financials

Omkar Pharmachem Technicals

EMA & SMA

Current Price
₹28.99
+ 0.71 (2.51%)
  • stock-down_img
  • Bullish Moving Average 0
  • stock-up_img
  • Bearish Moving Average 0
  • 20 Day
  • ₹26.25
  • 50 Day
  • ₹24.28
  • 100 Day
  • ₹22.01
  • 200 Day
  • -

Resistance and Support

28.99 Pivot Speed
  • R3 28.99
  • R2 28.99
  • R1 28.99
  • S1 28.99
  • S2 28.99
  • S3 28.99

What's your outlook on Omkar Pharmachem?

You can only vote for once

Omkar Pharmachem Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-12 Quarterly Results
2024-08-12 Quarterly Results
2024-05-30 Audited Results
2024-02-14 Quarterly Results
2023-11-10 Quarterly Results

Omkar Pharmachem F&O

Omkar Pharmachem Shareholding Pattern

No data available.

About Omkar Pharmachem

  • NSE Symbol
  • OMKARPH
  • BSE Symbol
  • 532167
  • ISIN
  • INE501C01015

Similar Stocks to Omkar Pharmachem

Omkar Pharmachem FAQs

Omkar Pharmachem share price is ₹28 As on 04 December, 2024 | 00:02

The Market Cap of Omkar Pharmachem is ₹29.2 Cr As on 04 December, 2024 | 00:02

The P/E ratio of Omkar Pharmachem is 155.6 As on 04 December, 2024 | 00:02

The PB ratio of Omkar Pharmachem is 3.2 As on 04 December, 2024 | 00:02

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23